AtriCure Enters Into Definitive Agreement to Acquire SentreHEART
Acquisition Expands Addressable Market Opportunity and Complements Offerings for the Treatment of Atrial Fibrillation Announces Updates to 2019 Outlook Conference…
Pharmaceuticals, Biotechnology and Life Sciences
Acquisition Expands Addressable Market Opportunity and Complements Offerings for the Treatment of Atrial Fibrillation Announces Updates to 2019 Outlook Conference…
The SIX-listed group RELIEF THERAPEUTICS Holding SA divests its subsidiary Relief Therapeutics SA to Sonnet BioTherapeutics Inc. (“Sonnet”). Sonnet commits…
HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC (Chemistry Manufacturing and Controls) development…
DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients/API – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Active Pharmaceutical…
DUBLIN–(BUSINESS WIRE)–The “Competent Cells – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Competent Cells market…
Partners to initiate Second Phase of R01-Awarded Research DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics, Inc. today announced that it has entered the…
BOSTON–(BUSINESS WIRE)–Akouos, a precision genetic medicine company developing gene therapies to restore and preserve hearing, today announced management will be…
Presented updated data from Phase 2 monotherapy arm of DeCidE1 study at ASCO 2019; DPX-Survivac exhibited durable clinical benefit with…
UGN-101 Rolling NDA Submission on Track for Q4 2019 with Planned Launch in 1H 2020 Final Topline UGN-101 Phase 3…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people…